A Continuing Cancer Service Model Emphasizing on Functional Restoration: Model for Breast Cancer
Primary Purpose
Breast Cancer, Quality of Life
Status
Unknown status
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
SG will be screened every time when they visit the clinics.
Sponsored by

About this trial
This is an interventional treatment trial for Breast Cancer focused on measuring Breast cancer, Care model, Physical Therapy
Eligibility Criteria
Inclusion Criteria:
- Women being newly diagnosed with breast cancer and first OPD visit after operation at National Taiwan University Hospital will be invited to join the surveillance and care system
Exclusion Criteria:
- Younger than 20 years old, stage IV, recurrent or both sides involved, with other cancer diagnosis, functional impairments from previous injury or operation on the affected upper extremity and other physical or mental problem to influence the test or filling the questionnaire.
Sites / Locations
- Graduate Scahool of Physical Therapy, College of Medicine, National Taiwan UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
surveillance group (SG)
general care group (CG)
Arm Description
SG will have health education brochure and free class from the first visit post-operatively but CG will only have the brochure. Moreover, SG will be screened every time when they visit the clinics. If there is any early sign of impairment, professional advice and counseling will be given additionally.
CG raises any health-related question, they can be answered.
Outcomes
Primary Outcome Measures
prevalence of body impairments
Standard physical examination including body composition, arm circumferences, shoulder range of motion and strength, grip strength, muscle length, posture, pain assessment will be performed at baseline and 5 time points of follow-up for both groups for detecting any kind of body impairment.
changes of functional status
several self-administrated questionnaires including ECOG, DASH, EORTC QLQ-C30, CFS, HADS will be used for assessing changes of functional status from baseline and 5 time points of follow-up.
Secondary Outcome Measures
Full Information
NCT ID
NCT01963572
First Posted
October 6, 2013
Last Updated
October 13, 2013
Sponsor
National Taiwan University Hospital
Collaborators
National Science Council, Taiwan
1. Study Identification
Unique Protocol Identification Number
NCT01963572
Brief Title
A Continuing Cancer Service Model Emphasizing on Functional Restoration: Model for Breast Cancer
Official Title
A Continuing Cancer Service Model Emphasizing on Functional Restoration: Model for Breast Cancer
Study Type
Interventional
2. Study Status
Record Verification Date
October 2013
Overall Recruitment Status
Unknown status
Study Start Date
August 2013 (undefined)
Primary Completion Date
July 2015 (Anticipated)
Study Completion Date
July 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Taiwan University Hospital
Collaborators
National Science Council, Taiwan
4. Oversight
5. Study Description
Brief Summary
Background and Purposes: Cancer is the leading cause of our mortality. It threatens people's life and quality of life (QOL). Although the incidence of cancer is still rising, with the promotion of cancer screening and progression of medical technology, its survival rate is improving. However, the sequels from cancer or its treatment and the side effects impact the patients along with their lives. Breast cancer is the most incident cancer in women with high survival rate, continuing care after the diagnosis and treatment is much more needed. This study is using breast cancer as an example to establish a continuing service model. This study aims (1) to establish a tailored, continuing care model which emphasizes on breast cancer patients' function. (2) To investigate the effectiveness of the new care model comparing with the control. (3) To find a cutting point of bioelectrical impedance to identify late development of lymphedema.
Methods: This is a randomized-controlled trial expanding for 3 years. Women being newly diagnosed with breast cancer and first OPD visit after operation at National Taiwan University Hospital will be invited to join the surveillance and care system. Exclusion criteria are: younger than 20 years old, stage IV, recurrent or both sides involved, with other cancer diagnosis, functional impairments from previous injury or operation on the affected upper extremity and other physical or mental problem to influence the test or filling the questionnaire. It is estimated there will be 100 subjects participate this study every year. After the initial evaluation, they will be randomly allocated to surveillance group (SG) or general care group (CG). Totally, in this three-year study, there will be 200 subjects (100/group), follow-up for 0.5 to 2 years. SG will have health education brochure and free class from the first visit post-operatively but CG will only have the brochure. Moreover, SG will be screened every time when they visit the clinics. If there is any early sign of impairment, professional advice and counseling will be given additionally. In these visits, if CG raises any health-related question, they can be answered. Detailed physical examination to identify their impairments and QOL are at 3, 6, 12, 18, 24 months after operation for both groups. Patients' characteristics, functional status, QOL will be presented by descriptive statistics. T-test/Mann-Whitney U test will be used to compare the differences between patients in two groups. Survival analysis and log-rank test will be used to show the prevalence of various functional impairments and test their difference. ROC curve will be used to find the cutting point for prediction of lymphedema.
Expected Results: It is expected (1) to set up the education program and brochure for breast cancer patients. (2) to establish a continuing surveillance and care model for breast cancer patients and extending to all cancers. (3) Women in the new care model will have less impairment and higher QOL comparing with women at the same post-operative stage. (4) To find out the prevalence of functional impairments from the data of control group. (5) A cutting point of bioelectrical impedance to identify late development of lymphedema will be found. (6) To train the team members of cancer care and research.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Quality of Life
Keywords
Breast cancer, Care model, Physical Therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
300 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
surveillance group (SG)
Arm Type
Experimental
Arm Description
SG will have health education brochure and free class from the first visit post-operatively but CG will only have the brochure. Moreover, SG will be screened every time when they visit the clinics. If there is any early sign of impairment, professional advice and counseling will be given additionally.
Arm Title
general care group (CG)
Arm Type
No Intervention
Arm Description
CG raises any health-related question, they can be answered.
Intervention Type
Other
Intervention Name(s)
SG will be screened every time when they visit the clinics.
Primary Outcome Measure Information:
Title
prevalence of body impairments
Description
Standard physical examination including body composition, arm circumferences, shoulder range of motion and strength, grip strength, muscle length, posture, pain assessment will be performed at baseline and 5 time points of follow-up for both groups for detecting any kind of body impairment.
Time Frame
2 years
Title
changes of functional status
Description
several self-administrated questionnaires including ECOG, DASH, EORTC QLQ-C30, CFS, HADS will be used for assessing changes of functional status from baseline and 5 time points of follow-up.
Time Frame
baseline, 3,6,12,18 and 24 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Women being newly diagnosed with breast cancer and first OPD visit after operation at National Taiwan University Hospital will be invited to join the surveillance and care system
Exclusion Criteria:
Younger than 20 years old, stage IV, recurrent or both sides involved, with other cancer diagnosis, functional impairments from previous injury or operation on the affected upper extremity and other physical or mental problem to influence the test or filling the questionnaire.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jau-Yih Tsauo, PhD
Phone
+886-2-33668130
Email
jytsauo@ntu.edu.tw
First Name & Middle Initial & Last Name or Official Title & Degree
Heuifen Lin, MS
Phone
+886-2-23123456
Ext
67740
Email
d96428001@ntu.edu.tw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jau-Yih Tsauo, PhD
Organizational Affiliation
Gratuate School of Physical Therapy, College of Medicine, National Taiwan University, Taipei, Taiwan
Official's Role
Principal Investigator
Facility Information:
Facility Name
Graduate Scahool of Physical Therapy, College of Medicine, National Taiwan University
City
Taipei
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jau-Yih Tsauo, PhD
Phone
+886-2-33668130
Email
jytsauo@ntu.edu.tw
First Name & Middle Initial & Last Name & Degree
Heuifen Lin, MS
12. IPD Sharing Statement
Learn more about this trial
A Continuing Cancer Service Model Emphasizing on Functional Restoration: Model for Breast Cancer
We'll reach out to this number within 24 hrs